These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


217 related items for PubMed ID: 25672163

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Evidence in support of hyperkalaemia management strategies: A systematic literature review.
    Palaka E, Leonard S, Buchanan-Hughes A, Bobrowska A, Langford B, Grandy S.
    Int J Clin Pract; 2018 Feb; 72(2):. PubMed ID: 29381246
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Evaluation of Appropriate Sodium Polystyrene Sulfonate Use With a Hyperkalemia Order Set: A Pilot Study.
    Mueller ZT, Crannage AJ.
    J Pharm Pract; 2019 Oct; 32(5):493-498. PubMed ID: 29642732
    [Abstract] [Full Text] [Related]

  • 28. Initiation of sodium polystyrene sulphonate and the risk of gastrointestinal adverse events in advanced chronic kidney disease: a nationwide study.
    Laureati P, Xu Y, Trevisan M, Schalin L, Mariani I, Bellocco R, Sood MM, Barany P, Sjölander A, Evans M, Carrero JJ.
    Nephrol Dial Transplant; 2020 Sep 01; 35(9):1518-1526. PubMed ID: 31377791
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Efficacy and safety of calcium polystyrene sulfonate in patients with hyperkalemia and stage 3-5 non-dialysis chronic kidney disease: a single-center randomized controlled trial.
    Wang X, Chen D, Song X, Wang J, Zhang H.
    J Int Med Res; 2023 Apr 01; 51(4):3000605231167516. PubMed ID: 37063062
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Sodium Zirconium Cyclosilicate (ZS-9): A Novel Agent for the Treatment of Hyperkalemia.
    Linder KE, Krawczynski MA, Laskey D.
    Pharmacotherapy; 2016 Aug 01; 36(8):923-33. PubMed ID: 27393581
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Use of Fludrocortisone for Hyperkalemia in Chronic Kidney Disease Not Yet on Dialysis.
    Lee EK, Yang WS.
    Electrolyte Blood Press; 2024 Jun 01; 22(1):8-15. PubMed ID: 38957547
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.